#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypophosphatasia Palmoplantar pustulosis Neuroendocrine carcinoma Hereditary motor and sensory neuropathy Fms-like tyrosine kinase 3 positive Pyruvate dehydrogenase complex deficiency Juvenile idiopathic arthritis Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Emphysema Arterial tortuosity syndrome Hereditary ataxia Langerhans cell sarcoma Infantile spasms Iron overload Acute on chronic liver failure More trials…

    Learn about Rare Diseases

    Hereditary angioedema Mantle cell lymphoma – Trials in Disease Mitochondrial myopathy Urea cycle disorder Noonan syndrome Langerhans’ cell histiocytosis – Trials in Disease Progressive multifocal leukoencephalopathy – Trials in Disease Vascular malformation Leiomyosarcoma – Life with Disease Glycogen storage disease type II More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pp1815 Diclofenac Epolamine Microcrystalline Cellulose Gskvx000000009151 Mps-106 Haloperidol Decanoate Human Vaccinia Immunoglobulin Hydrocortisone Hemisuccinate Betamethasone Acetate Larotrectinib Sulfate Rct2100 Ict01 MEGESTROL ACETATE Bexmarilimab Deucravacitinib A/H1N1 INFLUENZA VACCINE Tepotinib Testosterone Tenofovir Disoproxil Fumarate Tipiracil Hydrochloride More therapies…

    Learn about Your Condition

    Pustular psoriasis Cerebral palsy Small intestine adenocarcinoma Lichenoid keratosis Diabetes mellitus Papulopustular rosacea Optic atrophy Nervous system disorder Follicular thyroid cancer Transient ischaemic attack Dermatitis Petit mal epilepsy Myocardial ischaemia Multifocal motor neuropathy Peripheral artery thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Evaluating Higher Dose Nusinersen in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Nusinersen
    Germany Hungary Italy

  • Study Comparing Injection Therapy with Triamcinolone Acetonide and Triamcinolone Hexacetonide to Surgery for Carpal Tunnel Syndrome in Adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Carpal tunnel syndrome
    Investigated Drugs:
    • Triamcinolone Hexacetonide
    • Triamcinolone Acetonide
    Norway

  • Study to Predict Tofacitinib Effectiveness in Psoriatic Arthritis Patients Using Tofacitinib, Methotrexate, and Folic Acid

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Folic Acid, Anhydrous
    • Etanercept
    • Methotrexate
    The Netherlands

  • Effects of Diclofenac Diethylamine Gel on Physical Activity and Quality of Life in Patients with Mild Knee Osteoarthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Diclofenac Diethylamine
    Poland

  • Study of Nusinersen for Patients with Spinal Muscular Atrophy Previously Treated with Onasemnogene Abeparvovec

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Nusinersen
    Germany Italy Spain

  • Study on NVD-003 Bone Graft for Treating Congenital Pseudarthrosis of the Tibia in Children

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Congenital pseudarthrosis
    Investigated Drugs:
    • Autologous Adipose-Derived Stem Cells
    Belgium
Previous Page
1 … 56 57 58 59 60 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!